Dr. Michael Motz

Michael has more than twenty years of experience in the pharma and biotech industry and serves currently as the Chief Business Officer of Netris Pharma SA, a Lyon based clinical stage oncology biotech company. Prior to Netris, Michael served as CEO of Algobate AG, which was partnered with a European specialty pharma group as well as in Senior Business Development Leadership functions at Zealand Pharma, Roche, Novartis/Sandoz and ALTANA Pharma. Michael is a chemist by education and did his PhD in protein-protein interactions at the Max Planck Institute and at LION Bioscience AG.

Continue your tour